Heterotopic Pregnancy Secondary to in vitro Fertilization-Embryo Transfer: Risk Factors and Pregnancy Outcomes
Shaomi Zhu1, Yiyue Fan1, Ling Lan1
1School of Medical and Life Sciences/Reproductive & Women-Children Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Frontiers in Medicine
|July 11, 2022
Summary
Heterotopic pregnancy (HP) after in vitro fertilization-embryo transfer (IVF-ET) is linked to a history of ectopic pregnancy, multiple abortions, and tubal infertility. Surgical treatment outcomes depend on operative duration, ectopic mass size, and location.
Area of Science:
- Reproductive Medicine
- Gynecology
- Obstetrics
Background:
- The incidence of heterotopic pregnancy (HP) is increasing due to assisted reproduction technology (ART) and pelvic inflammatory disease.
- Risk factors and optimal management strategies for HP remain incompletely understood.
Purpose of the Study:
- To identify risk factors associated with heterotopic pregnancy (HP) following in vitro fertilization-embryo transfer (IVF-ET).
- To evaluate pregnancy outcomes in patients with HP who undergo surgical treatment.
Main Methods:
- A retrospective study comparing 29 patients with HP to 116 patients with intrauterine-only pregnancy (IUP) after IVF-ET.
- Analysis of patient histories, pregnancy outcomes, and surgical treatment parameters.
Main Results:
- Patients with HP had higher rates of previous ectopic pregnancies, multiple abortions (≥2), and tubal infertility as an indication for IVF.
- HP cases showed increased spontaneous abortion and preterm delivery rates, with lower live birth rates compared to IUP.
- Significant risk factors for HP included a history of multiple abortions, tubal infertility, previous ectopic pregnancies, and the number of embryos transferred.
- Surgical treatment success was associated with shorter operative times, smaller ectopic mass size, and tubal ampullary location.
Conclusions:
- A history of ectopic pregnancy, multiple abortions, tubal infertility, and multiple embryo transfers are significant risk factors for HP post-IVF-ET.
- Favorable reproductive prognosis after surgical management of HP is linked to shorter operative duration, smaller ectopic mass size, and ampullary location.
Related Concept Videos
In Vitro Fertilization
379
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
379
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K


